Citation Impact
Citing Papers
Bacteremia Associated With Toothbrushing and Dental Extraction
2008 Standout
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility
2003 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
2006
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia
1994
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Testicular Germ-Cell Cancer
1997 Standout
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation
2004
Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease
2002
Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation
1999
Invasive Fungal Disease in Adults Undergoing Remission-Induction Therapy for Acute Myeloid Leukemia: The Pathogenetic Role of the Antileukemic Regimen
1995
Ulcerative Colitis
2011 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Treatment of relapse after allogeneic bone marrow transplantation
1996
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients
2002
Evolution, Incidence, and Susceptibility of Bacterial Bloodstream Isolates from 519 Bone Marrow Transplant Patients
2001
Acute graft-vs-host disease
2001
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
2002
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
2006
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
1992
Lipid-based amphotericin B: a review of the last 10 years of use
2001
Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipients
1996
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
1989 StandoutNobel
What role do antibiotics have in the treatment of IBD?
2008
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Chemotherapy and the war on cancer
2005 Standout
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Graft-versus-host disease
2009 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
1994
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue
1992
Bone Marrow Transplantation
1994
Complement
2001 Standout
Childhood Leukemias
1995
Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype
1998
Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia
1997
Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
2011
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
2002
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series
1997
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial
2002
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
2005
Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment
2002
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
2000
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
1999
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation
2000
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
1992
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
An Analysis of Bacteremias During Dental Extractions
1996
How I treat refractory acute GVHD
2007
Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant
2003
Recombinant Toxins for Cancer Treatment
1991 Science
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
1991
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease
1994
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled study
2005
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
2003
Gastritis
2001
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Cytokines, platelet production and hemostasis
1997
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Varicella-zoster virus
1996 Standout
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
2008
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase
1988
Unrelated donor marrow transplantation in children
1995
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
2007
ANTIBIOTIC CONSIDERATIONS IN MEDICALLY COMPROMISED PATIENTS
1994
Monoclonal antibody-based therapies of leukemia and lymphoma
1992
Duration of immunosuppressive treatment for chronic graft-versus-host disease
2004
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Growth Factors and Cancer
1991 StandoutScience
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
2004
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of R Haake being referenced
Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4- hydroperoxycyclophosphamide for marrow purging
1990
Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental Challenge
2006
Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children.
1993
Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation
1987
Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens.
1990
Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation.
1987
In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia
1991
Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation
1987
The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients.
1990
Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy
1990
Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.
1994
Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.
1989
Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4- hydroperoxycyclophosphamide for marrow purging
1990
Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.
1991
Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission
1988
Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome
1990
Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome
1990
Allogeneic and autologous bone marrow transplantation for high risk acute lymphoblastic leukemia.
1992
Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
1994
Candida infections in bone marrow transplant recipients.
1991
Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy
1990
In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts [see comments]
1989
Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.
1987